Modeling hot flushes and quality of life in breast cancer survivors

Climacteric

Volumn 14, Issue 1, 2011, Pages 171-180

  Rand, K L ^a   Otte, J L ^b   Flockhart, D ^b   Hayes, D ^c   Storniolo, A M ^b   Stearns, V ^d   Henry, N L ^c   Nguyen, A ^b   Lemler, S ^b   Hayden, J ^c   Jeter, S ^d   Carpenter, J S ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

breast cancer; Hot flushes; menopause; quality of life; structural model

Indexed keywords

AROMATASE INHIBITOR;

ADULT; AGED; ANXIETY; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; DAILY LIFE ACTIVITY; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; FACTORIAL ANALYSIS; FEMALE; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOT FLASH RELATED DAILY INTERFERENCE SCALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF REPORT; SKIN CONDUCTANCE; SLEEP DISORDER; STRUCTURAL EQUATION MODELING;

ANXIETY; AROMATASE INHIBITORS; BREAST NEOPLASMS; DEPRESSION; FACTOR ANALYSIS, STATISTICAL; FEMALE; GALVANIC SKIN RESPONSE; HEALTH STATUS; HOT FLASHES; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; MONITORING, AMBULATORY; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; SURVIVORS;

EID: 79951666769     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697131003717070     Document Type: Article

References (59)

1. Hobbs F, Stoops N. Demographic Trends in the 21st Century. Washington, DC: US Census Bureau, Census 2000 Special Reports, Series CENSR-4
2. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003;290:1729-38 (Pubitemid 37430623)
3. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative randomized trial. JAMA 2003;289:3243-53 (Pubitemid 37430077)
4. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004 (Pubitemid 38269276)
5. Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004;292:1573-80 (Pubitemid 39314963)
6. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-34 (Pubitemid 36951364)
7. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33 (Pubitemid 34761611)
8. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-62 (Pubitemid 37430136)
9. Carpenter JS, Johnson D, Wagner L, Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002;29: E16-25
10. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 2002;23:501-9 (Pubitemid 34627035)
11. Lo Presti A, Ruvolo G, Gancitano RA, Cittadini E. Ovarian function following radiation and chemotherapy for cancer. Eur J Obstet Gynecol Reprod Biol 2004;113(Suppl 1): S33-40 (Pubitemid 38369303)
12. North American Menopause Society. Menopause Practice: A Clinician's Guide. Cleveland, OH: North American Menopause Society, 2004
13. Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA. Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 2006;99:215-20 (Pubitemid 44268270)
14. Kahn KL, Schneider EC, Malin JL, Adams JL, Epstein AM. Patient centered experiences in breast cancer: predicting longterm adherence to tamoxifen use. Med Care 2007;45:431-9
15. Demissie S, Silliman RA, Lash TL. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 2001;19:322-8 (Pubitemid 32112842)
16. Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057-71 (Pubitemid 44794007)
17. Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453-65 (Pubitemid 44125864)
18. Carroll DG. Nonhormonal therapies for hot flashes in menopause. Am Fam Physician 2006;73:457-64
19. Bruno D, Feeney KJ. Management of postmenopausal symptoms in breast cancer survivors. Semin Oncol 2006;33:696-707 (Pubitemid 44828121)
20. Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med 2005;118(12 Suppl 2):98-108S
21. Carpenter JS. State of the science: Hot flashes and cancer. Part 2: Management and future directions. Oncol Nurs Forum 2005;32:969-78
22. Stearns V, Loprinzi CL. New therapeutic approaches for hot flashes in women. J Support Oncol 2003;1:11-21
23. Wymenga AN, Sleijfer DT. Management of hot flushes in breast cancer patients. Acta Oncol 2002;41:269-75 (Pubitemid 34833051)
24. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol 2001;19:4280-90 (Pubitemid 33096775)
25. US Department of Health and Human Services (DHHS). Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms - recommendations for clinical evaluation: Draft guidance. Rockville: Food and Drug Administration Center for Drug Evaluation and Research (CDER); January 2003
26. Carpenter JS, Monahan PO, Azzouz F. Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstet Gynecol 2004;104:1322-6 (Pubitemid 40458730)
27. Sievert LL, Freedman RR, Garcia JZ, et al. Measurement of hot flashes by sternal skin conductance and subjective hot flash report in Puebla, Mexico. Menopause 2002;9:367-76 (Pubitemid 36701897)
28. Savard J, Davidson JR, Ivers H, et al. The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 2004;27:513-22 (Pubitemid 38686410)
29. Miller HG, Li RM. Measuring hot flashes: Summary of a National Institutes of Health workshop. Mayo Clin Proc 2004;79:777-81 (Pubitemid 38696921)
30. Carpenter JS. The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 2001;22:979-89 (Pubitemid 33152683)
31. Carpenter JS, Andrykowski MA, Freedman RR, Munn R. Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause 1999;6:209-15 (Pubitemid 29418964)
32. Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 1998;45(1 Spec No): 5-13 (Pubitemid 28339935)
33. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213 (Pubitemid 19144991)
34. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70 (Pubitemid 13098606)
35. Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003;1:29
36. Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in ambulatory cancer patients. Cancer 2005;103:1494-502
37. Carpenter JS, Andrykowski MA, Wilson J, et al. Psychometrics for two short forms of the Center for Epidemiologic Studies-Depression Scale. Issues Ment Health Nurs 1998;19:481-94 (Pubitemid 128475582)
38. Radloff IS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psych Meas 1977;1:385-401
39. McCallum J, MacKinnon A, Simons L, Simons J. Measurement properties of the Center for Epidemiological Studies Depression Scale: an Australian community study of aged persons. J Gerontol B Psychol Sci Soc Sci 1995;50: S182-9
40. Coyle CP, Roberge J. The psychometric properties of the Center for Epidemiological Studies-Depression Scale (CES-D) when used with physical disabilities. Psychol Health 1992;7:69-81
41. LISREL [computer program]. Version 8.8. Chicago: Scientific Software International, 2008
42. Little TD, Cunningham WA, Shahar G, Widaman KF. To parcel or not to parcel: exploring the question, weighing the merits. Structural Equation Modeling 2002;9:151-73
43. Steiger JH. Structural model evaluation and modification: an interval estimation approach. Multivariate Behavioral Res 1990;25:173-80
44. Browne MW, Cudeck, R. Alternative ways of assessing model fit. In Bollen KA, Long JS, eds. Testing Structural Equation Models. Newbury Park, CA: Sage, 1993:136-62
45. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling 1999;6:1-55
46. Enders CK. The performance of the full information maximum likelihood estimator in multiple regression models with missing data. Educat Psychol Measurement 2001;61:713-40
47. Carpenter JS, Rand KL. Modeling the hot flash experience in breast cancer survivors. Menopause 2008;15:469-75 (Pubitemid 351656751)
48. Thurston RC, Blumenthal JA, Babyak MA, Sherwood A. Association between hot flashes, sleep complaints, and psychological functioning among healthy menopausal women. Int J Behav Med 2006;13:163-72 (Pubitemid 43962735)
49. Beck SL, Dudley WN, Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. Oncol Nursing Forum 2005;32:542
50. Affleck G, Tennen H, Zautra A, Urrows S, Abeles M, Karoly P. Women's pursuit of personal goals in daily life with fibromyalgia: a value-expectancy analysis. J Consult Clin Psychol 2001;69:587-96 (Pubitemid 32803847)
51. Brunstein JC. Personal goals and subjective well-being: a longitudinal study. J Personality Soc Psychol 1993;65:1061-70
52. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990;592:52
53. Young T, Rabago D, Zgierska A, Austin D, Finn L. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin sleep cohort study. Sleep 2003;26:673-7
54. Polo-Kantola P, Erkkola R, Irjala K, Helenius H, Pullinen S, Polo O. Climacteric symptoms and sleep quality. Obstet Gynecol 1999;94:219-24 (Pubitemid 29352865)
55. Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs 2005;65:927-47 (Pubitemid 40663621)
56. Carpenter JS, Azzouz F, Monahan PO, Storniolo AM, Ridner SH. Is sternal skin conductance monitoring a valid measure of hot flash intensity or distress? Menopause 2005;12:512-9 (Pubitemid 41362074)
57. Caltabiano ML, Holzheimer M. Dispositional factors, coping and adaptation during menopause. Climacteric 1999;2:21-8 (Pubitemid 29253922)
58. Carpenter JS, Gilchrist JM, Chen K, Gautam S, Freedman RR. Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors. Menopause 2004;11:375-81 (Pubitemid 40362161)
59. Freedman RR. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998;70:332-7 (Pubitemid 28361490)